Embed

Academic

Authors

Francisco Javier Pavon

Francisco Javier Pavon (Francisco Javier Pavón),Universidad de Málaga,Neuroscience,Pharmacology,Medicinal Chemistry

Edit

Francisco Javier Pavon (Francisco Javier Pavón)

Universidad de Málaga

Publications: 6 | Citations: 85

Fields: Neuroscience, Pharmacology, Medicinal Chemistry

Collaborated with 27 co-authors from 2006 to 2011 | Cited by 313 authors

Cumulative Annual

Sort by:

Publications (6)

BibTeX | RIS | RefWorks Download

Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake (Citations: 1)

, , , , , ,

Journal: Neuropharmacology , vol. 60, no. 4, pp. 593-601, 2011

Oleoylethanolamide: a new player in peripheral control of energy metabolism. Therapeutic implications

, , , ,

Journal: Drug Discovery Today: Disease Mechanisms , vol. 7, no. 3, pp. e175-e183, 2010

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats (Citations: 23)

, , , , ,

Journal: Neuropharmacology , vol. 54, no. 1, pp. 226-234, 2008

Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats (Citations: 19)

, , , , , , , ,

Journal: Journal of Neuroendocrinology - J NEUROENDOCRINOL , vol. 20, no. s1, pp. 116-123, 2008

Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents (Citations: 2)

, , , , , , , , , ,

Journal: Bioorganic & Medicinal Chemistry - BIOORGAN MED CHEM , vol. 16, no. 23, pp. 10098-10105, 2008

Sort by:

Citations (85 times by 72 publications)

Inhibition of Gastric Lipase as a Mechanism for Body Weight and Plasma Lipids Reduction in Zucker Rats Fed a Rosemary Extract Rich in Carnosic Acid

, , , , , , , , ,

Journal: PLOS One , vol. 7, no. 6, 2012

Current and Future Drug Targets in Weight Management (Citations: 2)

Journal: Pharmaceutical Research - PHARMACEUT RES , vol. 28, no. 8, pp. 1-27, 2011

Asymptotic integration of ( 1 + α ) -order fractional differential equations

, ,

Journal: Computers & Mathematics With Applications - COMPUT MATH APPL , vol. 62, no. 3, pp. 1492-1500, 2011

Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies

Journal: Obesity , vol. 19, no. 7, pp. 1325-1334, 2011

1155 poster TOWARDS CERTIFICATION OF RTTS IN ISRAEL: A FIRST COURSE EXPERIENCE

Journal: Radiotherapy and Oncology - RADIOTHER ONCOL , vol. 99, pp. S430-S430, 2011

Comments

Co-authors (27)

Journals (4)

Keywords (22)

Francisco Javier Pavon (Francisco Javier Pavón),Universidad de Málaga,Neuroscience,Pharmacology,Medicinal Chemistry

Publications (6)

BibTeX | RIS | RefWorks Download

Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake (Citations: 1)

Oleoylethanolamide: a new player in peripheral control of energy metabolism. Therapeutic implications

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats (Citations: 23)

Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats (Citations: 19)

Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents (Citations: 2)

Citations (85 times by 72 publications)

Inhibition of Gastric Lipase as a Mechanism for Body Weight and Plasma Lipids Reduction in Zucker Rats Fed a Rosemary Extract Rich in Carnosic Acid

Current and Future Drug Targets in Weight Management (Citations: 2)

Asymptotic integration of ( 1 + α ) -order fractional differential equations

Rimonabant Redux and Strategies to Improve the Future Outlook of CB1 Receptor Neutral-Antagonist/Inverse-Agonist Therapies

1155 poster TOWARDS CERTIFICATION OF RTTS IN ISRAEL: A FIRST COURSE EXPERIENCE


	View FAQ about top research areas and Fields of study

Francisco Javier Pavon (Francisco Javier Pavón),Universidad de Málaga,Neuroscience,Pharmacology,Medicinal Chemistry

Publications (6) BibTeX | RIS | RefWorks Download

Oleoylethanolamide: Effects on hypothalamic transmitters and gut peptides regulating food intake (Citations: 1)

The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats (Citations: 23)

Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats (Citations: 19)

Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents (Citations: 2)

Current and Future Drug Targets in Weight Management (Citations: 2)

Publications (6)

BibTeX | RIS | RefWorks Download